Clinical Trials Logo

Thoracic Aortic Aneurysm clinical trials

View clinical trials related to Thoracic Aortic Aneurysm.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05650892 Active, not recruiting - Clinical trials for Thoracic Aortic Aneurysm

Male-female Differences in Immunohistological and Biomechanical Properties of the Thoracic Aorta

MAFATS
Start date: February 1, 2021
Phase:
Study type: Observational

Thoracic aortic aneurysms (TAA) result from progressive dilatation of the thoracic aorta and confer a risk for aortic dissection or rupture, which is associated with significant morbidity and mortality. In the Netherlands there are an estimated 200.000 adults with TAA, and annually 600 deaths after aortic dissection or rupture. There are clear differences in the incidence of TAA between men and women, with a higher incidence in men. Little is known on possible differences in outcome between male and female patients with Thoracic Aortic Aneurysm (TAA). Aortic disease is thought to affect men more frequently than women, and aortic growth is different between men and women. Current data suggest that women are at an increased risk of both dying from aortic dissection and having aorta-related complications compared to men (1). The mechanisms for these male-female difference in TAA outcome remain, however, unclear. The timing of preventive surgery is now not different for men and women, but gender-based cut-off values for maximal aortic diameter based on differences in vessel wall composition might be needed.

NCT ID: NCT05146375 Active, not recruiting - Clinical trials for Thoracic Aortic Aneurysm

Genes Modulating the Severity of Aortic Aneurysms (MSF1-TGFBR2)

MSF1-TGFBR2
Start date: November 24, 2022
Phase:
Study type: Observational

This project concerns a population at risk of sudden death by dissection of the thoracic aorta. Its interest is to make it possible to recognize the genes that protect or worsen the evolution of aneurysms, to better understand the mechanisms involved, to detect and treat aneurysms of the thoracic aorta, wich is a pathology that is completely silent clinically until life-threatening complications. The variability in the severity of the disease within the same family is related to modifier genes. The objective is to find the modifying factors that account for the variability in the severity of the progression of aneurysms of the thoracic aorta.

NCT ID: NCT05143138 Active, not recruiting - Clinical trials for Abdominal Aortic Aneurysm

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used as a Bridging Stent With Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries

EMBRACE
Start date: March 23, 2022
Phase:
Study type: Observational [Patient Registry]

Multicenter, single-arm retrospective and prospective registry is being conducted to confirm the clinical performance and safety of GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis when used as a Bridging Stent with Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries.

NCT ID: NCT01033214 Active, not recruiting - Clinical trials for Thoracic Aortic Aneurysm

ENTRUST - TAArget® Thoracic Stent Graft Clinical Trial

Start date: January 2010
Phase: Phase 1
Study type: Interventional

Evaluate the safety and effectiveness of endovascular repair with the LeMaitre TAArget thoracic stent graft as an alternative to open surgical repair.